Scribe CEO @BenjaminLOakes will join a fireside chat at @FierceBiotech's Cell & Gene Turning Point event on Thursday, 11/20. He'll discuss how CRISPR-based therapies could help prevent, not just treat, cardiovascular disease. Register for free here: https://t.co/J5acuxvHxl

#AHA25 Scientific Sessions are underway! Don’t miss key presentations by CSO Aarif Khakoo and SVP of Discovery Biology Maria Mirotsou. From #CRISPR gene editing to epigenetic silencing, we’ll share updates on our pipeline of therapies for cardiovascular disease.👇 @AHAScience

🥇 Our Computational Genomics & Data Science team won 1ST PLACE in AWS AI League for Startups SF! Huge shout-out to champion Mohit Pandey and full squad for showcasing Scribe’s growing AI innovation capabilities. Thanks to @awscloud for inviting us and a fantastic competition.

📣 #AHA25 is almost here! We’re headed to New Orleans to share the latest on our pipeline of #CRISPR genome editing & epigenetic silencing therapies for cardiometabolic disease. Details below on 4 presentations by our CSO Aarif Khakoo & SVP of Discovery Biology Maria Mirotsou 👇

How can we transform the standard of care for heart disease? ❤️‍🩹 Join us at #TCT2025 this Saturday to hear from our CEO @BenjaminLOakes, who will share promising #CRISPR gene editing and epigenetic silencing strategies at @crfheart's @TCTConference MedTech Innovation Forum.

Scribe's ELXR platform underpins STX-1150, our #CRISPR-based therapy designed to lower LDL-C and address cardiovascular disease effectively. Thanks to @MarJungle for interviewing our CEO @BenjaminLOakes and showcasing our innovative ELXR engineering work! @ESGCT @Clarivate

Listen to Scribe’s co-founder, Jennifer Doudna, speak to the vision that Scribe was founded on – unlocking #CRISPR to revolutionize the standard of care for cardiometabolic disease. "I really hope that gene editing technology, like CRISPR, becomes a preventative [therapy]..." 🧵

United States needs China the same way Batman needs Joker. Without China, the West is culturally set for complacency and decline. United States had no business in space until Soviets Sputnik-scared them. And I can only hope that Shanghai biotechs killing it on all fronts will

We've spent billions on treatments that patients can't stick to. 𝗔𝗻𝗱 𝘀𝘁𝗶𝗹𝗹, 𝗲𝘃𝗲𝗿𝘆 𝟯𝟰 𝘀𝗲𝗰𝗼𝗻𝗱𝘀, 𝘀𝗼𝗺𝗲𝗼𝗻𝗲 𝗱𝗶𝗲𝘀 𝗳𝗿𝗼𝗺 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗱𝗶𝘀𝗲𝗮𝘀𝗲. That's more than cancer, accidents, and diabetes combined. We’ve been solving the

Meet Scribe at #CGMesa25 in Phoenix 🌵 Our CFO David Parrot will be onsite at the @alliancerm Cell & Gene Meeting on the Mesa to present updates on our work engineering #CRISPR-based medicines for cardiometabolic disease. Swing by and learn more on Monday, Oct. 6 at 1:45pm MST.

We’re headed to #ESGCT2025 to share our latest #CRISPR #EpigeneticEditing data. Check out our presentation on Thursday, Oct. 9! 🧬 Engineering enhanced epigenetic editors: novel repressor domains drive potent and durable therapeutic gene silencing in non-human primates

Knowing your #cholesterol could save your life. This National #CholesterolEducationMonth, stay up to date on the impact cholesterol levels have on your risk for heart disease. 👇

We've spent billions on treatments that patients can't stick to. 𝗔𝗻𝗱 𝘀𝘁𝗶𝗹𝗹, 𝗲𝘃𝗲𝗿𝘆 𝟯𝟰 𝘀𝗲𝗰𝗼𝗻𝗱𝘀, 𝘀𝗼𝗺𝗲𝗼𝗻𝗲 𝗱𝗶𝗲𝘀 𝗳𝗿𝗼𝗺 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗱𝗶𝘀𝗲𝗮𝘀𝗲. That's more than cancer, accidents, and diabetes combined. We’ve been solving the

At Scribe, we run on teamwork and purpose – in and out of the lab. #JPMCC 2025 marked our 4th year participating in the global @jpmorgan Corporate Challenge. Check out our reel for highlights our team captured as they ran through San Francisco, repping our “ELXR” tech! 🧪😉

Building on the legacy of many, I'm incredibly excited that we have successfully translated our polygenic risk scores into a validated clinical assay @MassGenBrigham @broadinstitute, orderable by any clinician in the US today. 🧬To order: https://t.co/lmPHq57sKQ 🧬Announcement:

@tmodarressi @MassGenBrigham @broadinstitute @MGBResearchNews @MGHHeartHealth @BroadGenomics @harvardmed @MGHMedicine @mghcvrc @CGM_MGH @GenPrecisionMed @AHAScience The easiest is to select ‘Saliva.’ The kit will be shipped with a prepaid mailer, inclusive of the $255 cost. And yes the price is the same, regardless of whether all 8 conditions or a subset is chosen. We are working on improving the order process but we aren’t a company & just

If you’ll be in New York for the Cantor Global Healthcare Conference, our CEO @BenjaminLOakes and CFO David Parrot will be on site and available for one-on-one meetings between Sept. 3-5. Interested in connecting? Reach out through our website 👉 https://t.co/VbRvrWuBk6

Remarkable that US spending on pharmaceuticals is just ~1.6% of GDP. Amazingly good value for money considering the welfare gains. (And especially given the extent to which the US subsidizes the rest of the world.)

Check out our press release for more #ESCCongress presentation details: https://t.co/eGmc806ed9 @escardio #ESCCongress #WCCardio

At #ESCCongress for the latest on #CRISPR gene editing treatments for cardiometabolic disease? On Monday, CSO Aarif Khakoo will present late-breaking preclinical data on STX-1200, our novel CRISPR-CasX based gene editing therapy to reduce elevated Lp(a) & CVD risk. Read more 👇